Back to mobile site

More on BBIO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+36.8% Growth)
- Ratings (8.9 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BridgeBio Pharma (NQ:BBIO)
Delayed: 85.89 -4.28 (4.75%)
Prev. Close $90.17  
Open$90.81 
52 Wk High$ 
52 Wk Low$ 
Day High$91.00 
Day Low$84.86 
P/E N/A  
EPS$ 
Volume6,382,503 

Friends, Peers and Foes (?): PFE, HLXB, ARGX, CNTA, OWL (more...)

Jul 10, 2026 07:04 PM Form SCHEDULE 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jul 10, 2026 04:01 PM BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jul 9, 2026 04:22 PM Form 144 BridgeBio Pharma, Inc. Filed by: Cook Jennifer E.
Jul 9, 2026 04:12 PM Form 144 BridgeBio Pharma, Inc. Filed by: Ellis Andrea
Jul 2, 2026 04:24 PM Form 8-K BridgeBio Pharma, Inc. For: Jul 01
Jul 2, 2026 07:31 AM BridgeBio drug shows kidney benefits in heart disease study
Jul 2, 2026 07:30 AM Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM
Jul 1, 2026 07:30 AM BridgeBio raises $1 billion in convertible preferred equity
Jul 1, 2026 07:30 AM BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches
Jul 1, 2026 07:30 AM BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches
View All Articles

Entities mentioned with BBIO

View All Entities